Compare Fox Corp Class A (FOXA) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class A vs Regeneron Pharmaceuticals Inc — how do they compare? Fox Corp Class A trades at $61.87 (market cap $24.58B), while Regeneron Pharmaceuticals Inc trades at $796.8 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 3.3× Fox Corp Class A's market cap, and Fox Corp Class A pays the higher dividend (0.93%). Which is the better fit depends on your goals.
| FOXA | REGN | |
|---|---|---|
Market Cap | $24.58B | $82.06B |
Sector | Media | Health |
52-Week High | $76.11 | $812.27 |
52-Week Low | $48.79 | $555.51 |
Enterprise Value | $27.94B | $76.77B |
Dividend Yield | 0.93% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
